Valve Repair Improves the Outcome of Surgery for Mitral Regurgitation

  • Maurice Enriquez-Sarano
    From the Division of Cardiovascular Diseases and Internal Medicine (M.E.-S., A.J.T., R.L.F.), Section of Cardiovascular Surgery (H.V.S., T.A.O.), and Section of Biostatistics (K.R.B.), Mayo Clinic and Mayo Foundation, Rochester, Minn.
  • Hartzell V. Schaff
    From the Division of Cardiovascular Diseases and Internal Medicine (M.E.-S., A.J.T., R.L.F.), Section of Cardiovascular Surgery (H.V.S., T.A.O.), and Section of Biostatistics (K.R.B.), Mayo Clinic and Mayo Foundation, Rochester, Minn.
  • Thomas A. Orszulak
    From the Division of Cardiovascular Diseases and Internal Medicine (M.E.-S., A.J.T., R.L.F.), Section of Cardiovascular Surgery (H.V.S., T.A.O.), and Section of Biostatistics (K.R.B.), Mayo Clinic and Mayo Foundation, Rochester, Minn.
  • A. Jamil Tajik
    From the Division of Cardiovascular Diseases and Internal Medicine (M.E.-S., A.J.T., R.L.F.), Section of Cardiovascular Surgery (H.V.S., T.A.O.), and Section of Biostatistics (K.R.B.), Mayo Clinic and Mayo Foundation, Rochester, Minn.
  • Kent R. Bailey
    From the Division of Cardiovascular Diseases and Internal Medicine (M.E.-S., A.J.T., R.L.F.), Section of Cardiovascular Surgery (H.V.S., T.A.O.), and Section of Biostatistics (K.R.B.), Mayo Clinic and Mayo Foundation, Rochester, Minn.
  • Robert L. Frye
    From the Division of Cardiovascular Diseases and Internal Medicine (M.E.-S., A.J.T., R.L.F.), Section of Cardiovascular Surgery (H.V.S., T.A.O.), and Section of Biostatistics (K.R.B.), Mayo Clinic and Mayo Foundation, Rochester, Minn.

書誌事項

タイトル別名
  • A Multivariate Analysis

抄録

<jats:p> <jats:italic>Background</jats:italic> Mitral valve repair has been suggested as providing a better postoperative outcome than valve replacement for mitral regurgitation, but this impression has been obscured by differences in baseline characteristics and has not been confirmed in multivariate analyses. </jats:p> <jats:p> <jats:italic>Methods and Results</jats:italic> The outcomes in 195 patients with valve repair and 214 with replacement for organic mitral regurgitation were compared using multivariate analysis. All patients had preoperative echocardiographic assessment of left ventricular function. Before surgery, patients with valve repair were less symptomatic than those with replacement (42% in New York Heart Association functional class I or II versus 24%, respectively; <jats:italic>P</jats:italic> =.001), had less atrial fibrillation (41% versus 53%; <jats:italic>P</jats:italic> =.017), and had a better ejection fraction (63±9% versus 60±12%, <jats:italic>P</jats:italic> =.016). After valve repair, compared with valve replacement, overall survival at 10 years was 68±6% versus 52±4% ( <jats:italic>P</jats:italic> =.0004), overall operative mortality was 2.6% versus 10.3% ( <jats:italic>P</jats:italic> =.002), operative mortality in patients under age 75 was 1.3% versus 5.7% ( <jats:italic>P</jats:italic> =.036), and late survival (in operative survivors) at 10 years was 69±6% versus 58±5% ( <jats:italic>P</jats:italic> =.018). Late survival after valve repair was not different from expected survival. After surgery, ejection fraction decreased significantly in both groups but was higher after valve repair ( <jats:italic>P</jats:italic> =.001). Multivariate analysis indicated an independent beneficial effect of valve repair on overall survival (hazard ratio, 0.39; <jats:italic>P</jats:italic> =.00001), operative mortality (odds ratio, 0.27; <jats:italic>P</jats:italic> =.026), late survival (hazard ratio, 0.44; <jats:italic>P</jats:italic> =.001), and postoperative ejection fraction ( <jats:italic>P</jats:italic> =.001). </jats:p> <jats:p> <jats:italic>Conclusions</jats:italic> Valve repair significantly improves postoperative outcome in patients with mitral regurgitation and should be the preferred mode of surgical correction. The low operative mortality is an incentive for early surgery before ventricular dysfunction occurs. </jats:p>

収録刊行物

  • Circulation

    Circulation 91 (4), 1022-1028, 1995-02-15

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (8)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ